# EDGAR Filing Document

**Accession Number:** 0001913210
**File Stem:** 0001493152-23-002612
**Filing Date:** 2023-1
**Character Count:** 5147
**Document Hash:** a55a6f7f9d34cbd039019d7186c5dd06
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-002612.hdr.sgml**: 20230126

**ACCESSION NUMBER**: 0001493152-23-002612

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230126

**FILED AS OF DATE**: 20230126

**DATE AS OF CHANGE**: 20230126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bruush Oral Care Inc.
- **CENTRAL INDEX KEY:** 0001913210
- **STANDARD INDUSTRIAL CLASSIFICATION:** DENTAL EQUIPMENT & SUPPLIES [3843]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41460
- **FILM NUMBER:** 23558101

**BUSINESS ADDRESS:**
- **STREET 1:** 128 WEST HASTINGS STREET, UNIT 210
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6B 1G8
- **BUSINESS PHONE:** (844) 427-8774

**MAIL ADDRESS:**
- **STREET 1:** 128 WEST HASTINGS STREET, UNIT 210
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6B 1G8

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**Report of Foreign Private Issuer Pursuant to Rule 13** **a-16 or 15d-16 of the Securities Exchange Act of 1934**

---

| | |
|:---|:---|
| For the month of | **January 2023** |
| Commission File Number | 001-41460 |

---

**Bruush Oral Care Inc.**

(Translation of registrant's name into English)

**128 West Hastings Street, Unit 210**

**Vancouver, British Columbia V6B 1G8**

**Canada**

**(844) 427-8774**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

**INFORMATION CONTAINED IN THIS FORM 6-K REPORT**

On January 20, 2023, Bruush Oral Care Inc. (the "Company") received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that, based on the closing bid price of the Company's common stock, without par value (the "Common Stock"), for the last 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Requirement"), and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive trading days.

The Notice has no immediate effect on the listing of the Common Stock on the Nasdaq Capital Market. Pursuant to the Nasdaq Listing Rules, the Company has been provided an initial compliance period of 180 calendar days to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Common Stock must be at least $1.00 per share for a minimum of 10 consecutive trading days prior to July 19, 2023, and the Company must otherwise satisfy The Nasdaq Capital Market's requirements for listing.

If the Company does not regain compliance by July 19, 2023, the Company may be eligible for an additional time. To qualify, the Company would be required, among other things, to meet the continued listing requirement for the market value of its publicly held shares, as well as all other standards for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and would need to provide written notice of its intention to cure the bid price deficiency during the second compliance period. If the Company does not regain compliance within the allotted compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company's Common Stock will be subject to delisting. The Company would then be entitled to appeal Nasdaq's determination to a Nasdaq Listing Qualifications Panel and request a hearing.

The Company intends to monitor the closing bid price of the Common Stock and consider its available options to resolve the noncompliance with the Minimum Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with the Nasdaq Capital Market's continued listing requirements or that Nasdaq will grant the Company a further extension of time to regain compliance, if applicable.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | *Bruush Oral Care Inc.* | *Bruush Oral Care Inc.* |
|  |  | (Registrant) | (Registrant) |
| Date: | January 26, 2023 | By: | */s/ Aneil Singh Manhas* |
|  |  | Name: | Aneil Singh Manhas |
|  |  | Title: | Chief Executive Officer |

---